This report introduces SMMILe, a novel computational pathology method designed to improve both whole-slide image classification and spatial quantification across various cancers. While traditional multiple-instance learning models often sacrifice spatial detail for global accuracy, SMMILe utilizes a superpatch-based approach to maintain high-resolution diagnostic maps without losing predictive power. The researchers mathematically demonstrate that instance-level aggregation overcomes the limitations of previous models, which often produce skewed or incomplete attention maps. By benchmarking the system across eight datasets and six cancer types, the study proves that SMMILe consistently matches or exceeds state-of-the-art performance in tasks like metastasis detection and tumor grading. Ultimately, this framework provides a robust tool for explainable AI, allowing pathologists to accurately identify and visualize specific tissue phenotypes within massive digital images.

References:

• Gao Z, Mao A, Dong Y, et al. SMMILe enables accurate spatial quantification in digital pathology using multiple-instance learning[J]. Nature Cancer, 2025: 1-17.

This research paper presents a multiomic and spatial atlas of lung adenocarcinoma (LUAD) to determine how TP53 mutations reshape the cellular landscape of tumors. The study reveals that malignant cells with these mutations lose their alveolar identity and transition into a highly plastic, entropic state characterized by increased proliferation and hypoxia. Beyond the cancer cells, the researchers identified a distinct multicellular ecosystem where specific fibroblasts and macrophages coordinate to promote a prometastatic environment. Evidence also shows that these mutated tumors suffer from reduced vascularization due to inhibitory signaling between malignant and endothelial cells. Despite these aggressive features, the findings suggest that TP53-mutant tumors may be more sensitive to immune checkpoint blockade therapy due to an enrichment of specific immune interactions. This systematic approach provides a framework for understanding how genetic drivers dictate the complex spatial organization and treatment responses of human cancers.

References:

• Zhao W, Nguyen T T, Bhagwat A, et al. A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma[J]. Nature Cancer, 2025, 6(11): 1857-1879.

Researchers have constructed a comprehensive Developmental Cell Atlas of the Human Cerebellum by analyzing prenatal brain tissue from 9 to 21 post-conceptional weeks. This study utilized laser capture microdissection and single-nucleus transcriptomics to map the molecular and spatial landscape of the organ during critical growth phases. The data reveals that human cerebellar development involves extended proliferative activity and unique progenitor compartments not found in other species. By identifying 21 distinct cell types, the authors provide a vital resource for understanding how specific cellular programs contribute to motor and cognitive functions. Furthermore, the atlas helps pinpoint the origins of various neurological disorders, ranging from pediatric structural abnormalities to adult-onset ataxias. This work fills a significant gap in previous brain studies, which often underrepresented the early transcriptional dynamics of the human cerebellum.

References:

• Aldinger K A, Thomson Z, Phelps I G, et al. Spatial and cell type transcriptional landscape of human cerebellar development[J]. Nature neuroscience, 2021, 24(8): 1163-1175.

The paper introduces TabulaTIME, a massive pan-cancer single-cell resource that integrates data from over four million cells across 36 different cancer types. By utilizing advanced computational frameworks, the researchers identified a specific group of CTHRC1+ cancer-associated fibroblasts that reside at the boundary between healthy and malignant tissue. These cells appear to create a physical barrier that prevents immune cells from infiltrating the tumor. The study also highlights a profibrotic ecotype formed by the interaction of these fibroblasts with SLPI+ macrophages, which contributes to poor patient outcomes. Ultimately, this comprehensive landscape provides a navigational map for understanding the tumor microenvironment and identifying new therapeutic targets to overcome immune evasion.

References:

• Han Y, Zhang L, Sun D, et al. Spatiotemporal analyses of the pan-cancer single-cell landscape reveal widespread profibrotic ecotypes associated with tumor immunity[J]. Nature Cancer, 2025, 6(11): 1880-1898.

This research introduces SWIFT-seq, a novel single-cell sequencing workflow designed to monitor multiple myeloma through a simple blood draw. By analyzing circulating tumor cells (CTCs), the method provides a noninvasive alternative to painful bone marrow biopsies, which are often difficult to perform frequently. The study demonstrates that SWIFT-seq accurately identifies cytogenetic abnormalities and measures tumor proliferation using as few as ten cells. It further establishes a circulatory capacity signature that explains how specific genetic traits drive cancer cells into the bloodstream. Ultimately, this technology captures the genomic complexity and clonal dynamics of the disease, offering a powerful tool for routine clinical surveillance and improved patient prognostication.

References:

• Lightbody E D, Sklavenitis-Pistofidis R, Wu T, et al. SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursors[J]. Nature Cancer, 2025, 6(9): 1595-1611.

This research article from Nature Cancer explores how malignant cells reprogram their environment by physically transferring mitochondria to nearby fibroblasts. Using advanced imaging and genetic tracing, the authors demonstrate that this exchange occurs through tunneling nanotubes, thin bridges that connect the cells. Once they receive these foreign organelles, the fibroblasts undergo a metabolic shift and transform into cancer-associated fibroblasts (CAFs), which then actively support tumor growth. The study identifies the protein MIRO2 as the essential motor for this transport, noting that its depletion effectively halts the transformation process. These findings highlight a novel mechanism of tumorigenesis where cancer cells "infect" healthy stromal cells to create a more hospitable environment for progression. By validating these results in both mouse models and human skin cancer samples, the researchers provide a strong rationale for developing therapies that target mitochondrial trafficking to disrupt the tumor microenvironment.

References:

• Cangkrama M, Liu H, Wu X, et al. MIRO2-mediated mitochondrial transfer from cancer cells induces cancer-associated fibroblast differentiation[J]. Nature Cancer, 2025, 6(10): 1714-1733.

This research article examines how Pten deletion triggers the transformation of adult prostate basal cells into multi-lineage stem cells, leading to the initiation of invasive tumors. Through techniques like single-cell RNA sequencing, the authors discovered that this cellular plasticity occurs primarily in specific prostate regions and is driven by the activation of innate immunity and the NF-κB signaling pathway. The study highlights that the cell of origin significantly dictates how aggressive a tumor becomes, noting that cancers derived from basal cells often exhibit more inflammation and stromal infiltration than those from luminal cells. Genetic experiments further show that combining Pten loss with other mutations, such as Pik3ca or p53, dramatically accelerates the reprogramming process. Ultimately, the findings suggest that using pharmacological inhibitors to target these inflammatory pathways could provide new strategies for the prevention and treatment of prostate cancer.

References:

• Jiang C, Song Y, Rorive S, et al. Innate immunity and the NF-κB pathway control prostate stem cell plasticity, reprogramming and tumor initiation[J]. Nature Cancer, 2025, 6(9): 1537-1558.

This research article from Nature Cancer identifies a critical link between vascular health and the progression of cancer cachexia, the debilitating loss of muscle mass in cancer patients. Through various tumor models and human samples, the authors discovered that a reduction in muscle capillary density actually happens before visible muscle wasting occurs. The study pinpoints a specific biological pathway where tumors release a factor called activin A, which travels through the blood to suppress the protein PGC1α within the inner lining of blood vessels. This suppression causes endothelial dysfunction, leading to leaky vessels, inflammation, and eventual muscle cell death. Significantly, the researchers demonstrated that restoring endothelial PGC1α activity could preserve blood vessel integrity and protect muscle mass. These findings suggest that targeting the health of the circulatory system may offer a new therapeutic strategy for treating cancer-related wasting.

References:

• Kim Y M, Sanborn M A, Vijeth S, et al. Skeletal muscle endothelial dysfunction through the activin A–PGC1α axis drives progression of cancer cachexia[J]. Nature Cancer, 2025, 6(8): 1350-1369.

This research investigates how glioblastoma (GBM), an aggressive brain cancer, transitions from a localized mass to a lethal, infiltrative growth pattern. Using mouse models and human samples, scientists discovered that microglia—the brain's immune cells—are mobilized in "oncofields" ahead of the tumor to create organized invasion tracks. These immune cells transform into oncostreams, which are longitudinal structures that physically guide collective cancer cell migration and restructure the extracellular matrix. A key molecular finding identifies the plexin-B2 receptor in immune cells as the essential regulator that allows these tracks to form. When this receptor is removed, the cancer loses its ability to infiltrate and is forced back into a less mobile bulk expansion state. This study highlights how targeting the physical coordination between the tumor microenvironment and cancer cells could provide new ways to halt brain cancer spread.

References:

• Kang S, Ughetta M E, Zhang J Y, et al. Glioblastoma shift from bulk to infiltrative growth is guided by plexin-B2-mediated microglia alignment in invasive niches[J]. Nature cancer, 2025, 6(9): 1505-1523.

This research article from Nature Cancer investigates the specific role of neutrophils in the progression of breast cancer through advanced genetic sequencing techniques. By studying both healthy and cancerous mammary glands, the researchers discovered that neutrophils re-emerge during late-stage carcinoma to physically interact with tumor cells. These interactions create a specialized signaling niche where tumor-activated macrophages recruit neutrophils to promote cell proliferation, invasion, and angiogenesis. The study identifies a distinct molecular signature in these interacting cells that correlates with significantly lower survival rates in human patients. Ultimately, these findings offer a new perspective on the tumor microenvironment and highlight potential biomarkers and therapeutic targets for treating aggressive breast cancer.

References:

• Camargo S, Moskowitz O, Giladi A, et al. Neutrophils physically interact with tumor cells to form a signaling niche promoting breast cancer aggressiveness[J]. Nature Cancer, 2025, 6(3): 540-558.